A comprehensive approach is recommended for management of cardiovascular risk factors among patients with T2D, according to an American Heart Association scientific statement published in Circulation. Joshua J. Joseph, MD, MPH, and colleagues developed a scientific statement based on current evidence relating to cardiovascular health in patients with T2D. The researchers note that management of cardiovascular risk factors remains poor in T2D, with many patients not meeting control targets for A1C, blood pressure, LDL cholesterol, and BMI. A comprehensive approach to management of all cardiovascular risk factors is recommended for patients with T2D, including glycemia, blood pressure, lipid abnormalities, thrombotic risk, obesity, and smoking. Lifestyle and pharmaceutical interventions with proven benefit are recommended using a patient-centered approach. In addition to clinical care and treatment, social determinants of health must be considered.